Emily Jeffcott joined Morgan & Morgan’s Pensacola office in 2019 as a trial attorney. She is licensed to practice law in Louisiana, Texas, New York and the District of Columbia. Her practice areas extend primarily to product liability multi-district litigation, focusing on science & expert development, trial practice, and law & briefing. Ms. Jeffcott was recently appointed to the Plaintiffs Steering Committee for In re: Juul Labs, Inc. Marketing, Sales Practices & Products Liability Litigation. In addition, Ms. Jeffcott is a member of the trial team and Plaintiffs’ Steering Committee for In re: Taxotere Products Liability Litigation, serving on as co-chair for the law & briefing committee and a member of the science committee. Ms. Jeffcott is also a member of Plaintiffs’ Steering Committee for In re: Valsartan (NDMA) Contamination Products Liability Litigation. Ms. Jeffcott’s past multi-district litigation experience includes In re: Xarelto. Products Liability Litigation, where she served as trial counsel in all bellwether trials, in addition to In re: Zofran Products Liability Litigation, In re: FEMA Trailer Products Liability Litigation, and In re: Deepwater Horizon Oil Spill.
Ms. Jeffcott has also represented whistleblowers across the country. Prior to joining Morgan & Morgan, Ms. Jeffcott was lead counsel for Relators in a $125 million qui tam settlement against Bechtel for alleged false claims related to the Hanford Nuclear Waste Treatment Plant in Washington. Ms. Jeffcott has also litigated cases involving Medicare fraud.
A 2009 graduate of St. Mary’s University School of Law, Ms. Jeffcott received numerous accolades for her oral advocacy skills and brief writing, including being named the ABA’s third-best advocate in the United States. An avid reader and writer, Ms. Jeffcott publishes regularly in legal journals and magazines distributed worldwide.